Arthroplasty, Fracture Fixation, Orthopedic Procedures
Conditions
Brief summary
This is a prospective observational case study, focusing on the clinical effectiveness of oral strong opioids for pain management following common orthopedic surgeries.The study aims to evaluate the effectiveness of multimodal analgesia with oral strong opioids, reduce common opioid-related side effects, and improve patient compliance and satisfaction.
Interventions
DRUGMultimodal analgesia with oral strong opioids
Physician's choice of post-surgical multimodal analgesia with an oral strong opioid as the backbone analgesics
Sponsors
Tri-Service General Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Aged 18 or older 2. Must undergo one of the following treatments: (1) Fracture of upper or lower limbs or pelvis requiring internal fixation surgery (2) Spinal fusion surgery (3) Joint replacement surgery 3. Requiring multimodal analgesics for postoperative pain control, with oral strong opioids as the primary opioid analgesic, as assessed by his/her physician. 4\. Voluntarily sign the informed consent form and agree to the collection of clinical questionnaires and medical-related information for this study.
Exclusion criteria
1. Patients who have not received any or have only received oral potent opioids for no more than 1 day during the postoperative hospitalization period (including those known to be intolerant or allergic to opioid medications). 2. Patients who have received or are expected to use long-acting opioid injections within 7 days before surgery or during the postoperative hospitalization period. 3. Patients who use patient-controlled analgesics for pain control after surgery. 4. Patients with a history of substance abuse or who require continuous treatment with other opioid receptor agonists or antagonists (such as naloxone or methadone). 5. Patients with a history of mental illness who continue to require medication control from 28 days before surgery and until discharge. 6. Other cases deemed ineligible by the study investigator.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in pain scores from baseline | Twice daily during hospitalization (approximately within 1 week), at the first return 1 day visit and at 3 months after surgery | Assess the efficacy of including oral strong opioids in multimodal pain control. For this objective, we will observe changes in pain scores among participants during postoperative treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Occurence of adverse events | During hospitalization (approximately within 1 week) | Avoid common adverse reactions associated with traditional morphine-like drugs, such as respiratory depression and addiction, to enhance treatment safety and patient comfort. We will monitor the occurrence rate of adverse reactions related to oral potent opioids. |
| Compliance of oral strong opioids | During hospitalization (approximately within 1 week) | Improvement the convenience of analgesic medication by transitioning from injections to oral administration, making it easier for patients to accept and adhere to the treatment plan. The compliance rate of oral strong opioids will be measured. |
| Physician's global impression - improvement scale(CGI-I) | During hospitalization (approximately within 1 week), at the first return 1 day visit and at 3 months after surgery | Effectiveness of the pain control will be assessed by a 7-point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention. Scale 1= Very much improved and scale 7 = very much worse |
| Satisfation of the pain control as per patients' report outcome | End of hospitalization (approximately 1 week after surgery) | Enhance patient acceptance of the treatment by using oral administration, boosting confidence in the treatment plan and increasing adherence and effectiveness. Patient satisfaction and pain improvement will be assessed through a 5-point scale questionnaire. 1=very much discontent, 2=discontent, 3=fair, 4=satisfied, 5=very much satisfied. |
Countries
Taiwan
Contacts
Primary ContactTsu-te Yeh, MD
Backup ContactTim TH Wang, PhD
Outcome results
None listed